Table 1. Patient Characteristics.
GD (n = 36) | |
---|---|
Age (years) | 45.3 ± 13.8 |
Sex (M:F) | 10:26 |
Previous treatment history due to GD (yes:no) | 10:26 |
T3 (ng/dL) | 262.8 ± 118.8 |
Free T4 (ng/dL) | 3.22 ± 2.72 |
T3/free T4 ratio | 91.4 ± 24.4 |
TSH (µIU/mL) | 0.05 ± 0.01 |
TSHR-Ab (IU/L) | 17.7 ± 24.8 |
Initial MMI dose (mg/day) | 19.4 ± 8.4 |
T3 (79–200 ng/dL), free T4 (0.89–1.79 ng/dL), TSH (0.3–4.0 µIU/mL), and TSHR-Ab (0–1.0 IU/L). GD = Graves' disease, MMI = methimazole, TSH = thyroid-stimulating hormone, TSHR-Ab = thyroid-stimulating hormone receptor antibody